Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
S2N28
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2GΔHR2 I3-01v9 SApNP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/19/2021
SΔC-Fer
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/05/2021
RBD-SpyVLP
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/22/2021
Stenoparib
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
CR-31-B (-)
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/08/2021
mAb Beta-53
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
sMVA-N/S
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
Noscapine
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
MXB-9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
Berzosertib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Ferroquine
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/08/2020
Celgosivir
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2020
MXB-4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
mAb Beta-27
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
mAb Beta-47
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
Isocyclosporin A
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
Cyclosporin B
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
7-bromo-5-chloro-8-hydroxyquinoline
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
FC05
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/29/2021